JPWO2018032012A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2018032012A5
JPWO2018032012A5 JP2019507271A JP2019507271A JPWO2018032012A5 JP WO2018032012 A5 JPWO2018032012 A5 JP WO2018032012A5 JP 2019507271 A JP2019507271 A JP 2019507271A JP 2019507271 A JP2019507271 A JP 2019507271A JP WO2018032012 A5 JPWO2018032012 A5 JP WO2018032012A5
Authority
JP
Japan
Prior art keywords
alkyl
disease
compound
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019507271A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019524814A (ja
JP2019524814A5 (https=
JP7140748B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/046807 external-priority patent/WO2018032012A1/en
Publication of JP2019524814A publication Critical patent/JP2019524814A/ja
Publication of JP2019524814A5 publication Critical patent/JP2019524814A5/ja
Publication of JPWO2018032012A5 publication Critical patent/JPWO2018032012A5/ja
Application granted granted Critical
Publication of JP7140748B2 publication Critical patent/JP7140748B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019507271A 2016-08-12 2017-08-14 アミド化合物、その医薬組成物、及びその使用方法 Active JP7140748B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662374657P 2016-08-12 2016-08-12
US62/374,657 2016-08-12
PCT/US2017/046807 WO2018032012A1 (en) 2016-08-12 2017-08-14 Amide compounds, pharmaceutical compositions thereof, and methods of using the same

Publications (4)

Publication Number Publication Date
JP2019524814A JP2019524814A (ja) 2019-09-05
JP2019524814A5 JP2019524814A5 (https=) 2022-08-01
JPWO2018032012A5 true JPWO2018032012A5 (https=) 2022-08-01
JP7140748B2 JP7140748B2 (ja) 2022-09-21

Family

ID=61163345

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019507271A Active JP7140748B2 (ja) 2016-08-12 2017-08-14 アミド化合物、その医薬組成物、及びその使用方法

Country Status (10)

Country Link
US (1) US11325886B2 (https=)
EP (1) EP3497077A4 (https=)
JP (1) JP7140748B2 (https=)
KR (1) KR102537274B1 (https=)
CN (1) CN109843849B (https=)
AU (1) AU2017310535B2 (https=)
IL (1) IL264765B2 (https=)
MX (1) MX394123B (https=)
RU (1) RU2759913C2 (https=)
WO (1) WO2018032012A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL276592B2 (en) * 2018-02-14 2023-11-01 Univ Oregon Health & Science History of Subtirum
EP3894383A1 (en) * 2018-12-12 2021-10-20 Autobahn Therapeutics, Inc. Novel thyromimetics
US12338206B2 (en) * 2019-02-21 2025-06-24 Nanjing Ruijie Pharma Co., Ltd. Compounds and their uses as thyroid hormone receptor agonists
CA3130371A1 (en) * 2019-03-01 2020-09-10 Autobahn Therapeutics, Inc. Novel thyromimetics
KR20220121239A (ko) 2019-11-29 2022-08-31 아우토반 쎄라퓨틱스, 인크. 신규한 갑상선 호르몬 모방제
JP7813730B2 (ja) * 2020-06-17 2026-02-13 オートバーン セラピューティクス,インク. 甲状腺様作用剤
WO2021257851A1 (en) 2020-06-17 2021-12-23 Autobahn Therapeutics, Inc. Thyromimetics
WO2023177667A1 (en) * 2022-03-16 2023-09-21 Brii Biosciences, Inc. Thyroid hormone receptor agonists
WO2025019825A2 (en) * 2023-07-20 2025-01-23 Brii Biosciences, Inc. Substituted 2-(3,5-dichloro-4-(4-hydroxy-benzyl)phenoxy)acetamide derivatives

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4320444A1 (de) * 1993-06-21 1994-12-22 Agfa Gevaert Ag Farbfotografisches Aufzeichnungsmaterial
US5883294A (en) * 1997-06-18 1999-03-16 The Regeants Of The University Of California Selective thyroid hormone analogs
GB9828442D0 (en) 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
US6436990B1 (en) 1999-10-27 2002-08-20 Nobex Corporation 6-methoxy-2-naphthylacetic acid prodrugs
US6429223B1 (en) 2000-06-23 2002-08-06 Medinox, Inc. Modified forms of pharmacologically active agents and uses therefor
WO2006128058A2 (en) 2005-05-26 2006-11-30 Metabasis Therapeutics, Inc. Thyromimetics for the treatment of fatty liver diseases
WO2006128056A2 (en) 2005-05-26 2006-11-30 Metabasis Therapeutics, Inc. Novel phosphinic acid-containing thyromimetics
CN101180097A (zh) 2005-05-26 2008-05-14 症变治疗公司 新型含次膦酸的拟甲状腺素药
GB0608724D0 (en) * 2006-05-03 2006-06-14 Karobio Ab Novel Pharmaceutical Compositions
WO2014178892A1 (en) 2013-05-03 2014-11-06 Scanlan Thomas S Use of sobetirome in the treatment of x-linked adrenolenoleukodystrophy
EP3259246B1 (en) * 2015-02-20 2023-03-22 Oregon Health & Science University Derivatives of sobetirome

Similar Documents

Publication Publication Date Title
RU2019106656A (ru) Амидные соединения, содержащие их фармацевтические композиции и способы их применения
JP2019524814A5 (https=)
JPWO2018032012A5 (https=)
RU2018107227A (ru) Терапевтические и профилактические антибактериальные средства
JP2016510317A5 (https=)
JP2007517059A5 (https=)
CA2465117A1 (en) Lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases
US20170100352A1 (en) Methods for treating or preventing neuroinflammation or autoimmune diseases
CN113365998A (zh) 用于parp抑制剂的吲哚并七元酰肟类似物
JP2012526791A5 (https=)
JP2018510849A (ja) ソベチロムの誘導体
JPWO2023099623A5 (https=)
JP2012505238A5 (https=)
WO2007127137B1 (en) Disubstituted aniline compounds
RU2009102278A (ru) Модуляторы рецептора s1p для лечения рассеянного склероза
JP2005533013A5 (https=)
CA2486380A1 (en) N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
DK173553B1 (da) Aminosyrederivater, antikonvulsant præparat som indeholder aminosyrederivat samt anvendelse af aminosyrederivater til frems
KR102714037B1 (ko) 자가면역 질환 치료용 조성물 및 방법
RU2010136954A (ru) Фенилпрениловые производные морского и синтетического происхождения для лечения нарушения познавательной способности, нейродегенеративных или нервных заболеваний или нарушений
CN1035939C (zh) 取代的(芳烷基氨基苄基)氨基丙酰胺衍生物及其制备方法
JP2020533402A5 (https=)
JPWO2021108549A5 (https=)
ATE289583T1 (de) Stereoisomere von propyl-isopropylacetamid, verfahren zu deren herstellung sowie diese enthaltende pharmazeutische zubereitungen
JP3479658B2 (ja) 神経変性障害処置のためのベンズアミド